EP Patent

EP4501404A2 — SOLID PHARMACEUTICAL COMPOSITION CONTAINING 2-{4-[N-(5,6-DIPHENYLPYRAZIN-2-YL)-N-ISOPROPYLAMINO!BUTYLOXY}-N-(METHYLSULFONYL)ACETAMIDE

Assigned to Nippon Shinyaku Co Ltd · Expires 2025-02-05 · 1y expired

What this patent protects

The present invention relates to a solid preparation comprising: 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; and D-mannitol having a specific surface area larger than 0.2 m 2 /g and smaller than 0.7 m 2 /g.

USPTO Abstract

The present invention relates to a solid preparation comprising: 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; and D-mannitol having a specific surface area larger than 0.2 m 2 /g and smaller than 0.7 m 2 /g.

Drugs covered by this patent

Patent Metadata

Patent number
EP4501404A2
Jurisdiction
EP
Classification
—
Expires
2025-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Shinyaku Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.